12:02 PM EST, 02/20/2025 (MT Newswires) -- Celanese (CE) faces a challenging H1 that could lead to an even slower-than-expected pace of recovery, UBS Securities said in a note Wednesday.

UBS said it expects a number of one-time items to weigh on the company's Q1 period, along with order timing and added turnarounds. The Q2 period is more indicative, according to the investment firm, though it also lowered its earnings estimates for the quarter.

Earnings are still slated to improve in the back half, buoyed by cost savings, UBS said in the note, adding that normalization of production could also improve earnings, but the timeline remains unclear.

UBS lowered its price target on Celanese stock to $60 from $72, while retaining a neutral rating.

Celanese shares were down more than 4% in recent Thursday trading.

Price: 52.36, Change: -2.56, Percent Change: -4.65